Khalid Benbatoul
Impact in
-
- Drug Transport and Resistance Mechanisms
-
- Cancer therapeutics and mechanisms
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
Papers in
-
- Cancer therapeutics and mechanisms 2
- DNA Repair Mechanisms 2
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Sonja Krane (5 shared papers)Ross Dixon (4 shared papers)Edmund J. Moran (4 shared papers)Chengzhi Zhang (3 shared papers)Michael Newman (1 shared paper)Emma S. Tomlinson Guns (1 shared paper)Roy T. Uyeda (1 shared paper)Lawrence D. Mayer (1 shared paper)
- Journals
- Blood (8 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Khalid Benbatoul
25 papers receiving 542 citations
Peers
Comparison fields: 5 of 69
- Oncology 232
- Molecular Biology 284
- Organic Chemistry 116
- Infectious Diseases 52
- Genetics 29
Countries citing papers authored by Khalid Benbatoul
This map shows the geographic impact of Khalid Benbatoul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Benbatoul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Benbatoul more than expected).
Fields of papers citing papers by Khalid Benbatoul
This network shows the impact of papers produced by Khalid Benbatoul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Benbatoul. The network helps show where Khalid Benbatoul may publish in the future.
Co-authors
The 25 scholars most cited alongside Khalid Benbatoul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. | 2000 | 160 |
| 2 | 2018 | 68 | |
| 3 | 2007 | 55 | |
| 4 | 2000 | 53 | |
| 5 | 1998 | 49 | |
| 6 | 2008 | 42 | |
| 7 | 2000 | 37 | |
| 8 | Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancer. | 1999 | 21 |
| 9 | 2,4,5-三置換イミダゾール P-糖蛋白質媒介多剤耐性の新規無毒モジュレータ 2 | 2000 | 18 |
| 10 | 2004 | 15 | |
| 11 | 2000 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 4 | |
| 14 | 2021 | 4 | |
| 15 | 2001 | 3 | |
| 16 | 2016 | 3 | |
| 17 | 2018 | 3 | |
| 18 | 2017 | 2 | |
| 19 | 2017 | 2 | |
| 20 | 2020 | 2 |
About Khalid Benbatoul
Khalid Benbatoul is a scholar working on Molecular Biology, Genetics, Oncology, Hematology and Organic Chemistry, having authored 25 papers that have together received 564 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Acute Myeloid Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Drug Transport and Resistance Mechanisms (4 papers), HIV/AIDS drug development and treatment (3 papers), Ferrocene Chemistry and Applications (3 papers), Cancer therapeutics and mechanisms (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Oncology (232 citations), Molecular Biology (284 citations), Organic Chemistry (116 citations), Infectious Diseases (52 citations) and Genetics (29 citations). Khalid Benbatoul has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Sonja Krane, Ross Dixon, Edmund J. Moran, Chengzhi Zhang, Michael Newman, Emma S. Tomlinson Guns, Roy T. Uyeda, Lawrence D. Mayer, Suzanne J. Romano and Adnan M.M. Mjalli. Their work appears in journals such as Blood, Bioorganic & Medicinal Chemistry Letters, Cancer Research, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.